A

Aura Biosciences
D

AURA

6.98000
USD
0.14
(2.05%)
Post Trading·7.14000USD+0.16000(+2.29%)
حجم التداول
45,617
الربح لكل سهم
-2
العائد الربحي
-
P/E
-4
حجم السوق
721,638,175
أصول ذات صلة المقالات
المزيد

العنوان: Aura Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.